Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Aradigm, CyDex Inc., United Therapeutics deal

The partners will co-develop and co-commercialize combination therapies to treat asthma and chronic obstructive pulmonary disease (COPD) using ARDM's AERx Essence inhaler and CyDex's

Read the full 240 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE